About Beyond Air
Beyond Air is a company based in Garden City (United States) founded in 2011 by Amir Avniel.. The company has 61 employees as of March 31, 2024. Beyond Air offers products and services including LungFit PH and LungFit Products. Beyond Air operates in a competitive market with competitors including MannKind Corp, OptiNose, Impel NeuroPharma, Alexza and Qnovia, among others.
- Headquarter Garden City, United States
- Employees 61 as on 31 Mar, 2024
- Founders Amir Avniel
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Beyond Air, Inc.
-
Annual Revenue
$3.71 M219.67as on Mar 31, 2024
-
Net Profit
$-46.63 M22.6as on Mar 31, 2024
-
EBITDA
$-40.97 M32.46as on Mar 31, 2024
-
Latest Funding Round
$20.6 M (USD), Post-IPO
Sep 26, 2024
- Investors
-
Employee Count
61
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Beyond Air
Beyond Air is a publicly listed company on the NASDAQ with ticker symbol XAIR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Beyond Air
Beyond Air offers a comprehensive portfolio of products and services, including LungFit PH and LungFit Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
FDA-approved for nitric oxide therapy in pulmonary hypertension treatments.
Generate on-demand nitric oxide for various respiratory applications.
Unlock access to complete
Unlock access to complete
Funding Insights of Beyond Air
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $20.6M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Post-IPO - Beyond Air | Valuation |
investors |
|
| Jun, 2024 | Amount | Post-IPO - Beyond Air | Valuation |
investors |
|
| Jun, 2023 | Amount | Post-IPO - Beyond Air | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Beyond Air
Beyond Air has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Cystic Fibrosis Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research funding and support for cystic fibrosis patients are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Beyond Air
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Beyond Air
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Beyond Air Comparisons
Competitors of Beyond Air
Beyond Air operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MannKind Corp, OptiNose, Impel NeuroPharma, Alexza and Qnovia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of small-molecule drugs
|
|
| domain | founded_year | HQ Location |
Developer of smart devices for nasal drug delivery
|
|
| domain | founded_year | HQ Location |
Intranasal delivery technology for CNS diseases is developed.
|
|
| domain | founded_year | HQ Location |
Developer of products for the treatment of acute and intermittent conditions
|
|
| domain | founded_year | HQ Location |
Inhaled drug delivery devices are developed for pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Inhalation devices for medical applications are developed by Iconovo.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Beyond Air
Frequently Asked Questions about Beyond Air
When was Beyond Air founded?
Beyond Air was founded in 2011 and raised its 1st funding round 10 years after it was founded.
Where is Beyond Air located?
Beyond Air is headquartered in Garden City, United States.
Who is the current CEO of Beyond Air?
Steve Lisi is the current CEO of Beyond Air.
How many employees does Beyond Air have?
As of Mar 31, 2024, the latest employee count at Beyond Air is 61.
What is the annual revenue of Beyond Air?
Annual revenue of Beyond Air is $3.71M as on Mar 31, 2024.
What does Beyond Air do?
Beyond Air was founded in 2011 and is headquartered in Garden City, United States. Medical devices for respiratory conditions are developed by the company, focusing on the LungFit system, which generates and delivers nitric oxide to intubated and non-intubated patients. An additional delivery system is provided for controlled gas administration. Operations center on innovation in respiratory care, with leadership including CEO Steve Lisi and Co-Founder COO Amir Avniel.
Who are the top competitors of Beyond Air?
Beyond Air's top competitors include MannKind Corp, OptiNose and Impel NeuroPharma.
What products or services does Beyond Air offer?
Beyond Air offers LungFit PH and LungFit Products.
Is Beyond Air publicly traded?
Yes, Beyond Air is publicly traded on NASDAQ under the ticker symbol XAIR.
Who are Beyond Air's investors?
Beyond Air has 1 investor. Key investors include Cystic Fibrosis Foundation.
What is Beyond Air's ticker symbol?
The ticker symbol of Beyond Air is XAIR on NASDAQ.